BGMA Urges UK To Hold Firm On Trade Deals

Insists Patent And Exclusivity Provisions Must Not Block Access

 
• By Dave Wallace

Responding to UK government statements on the country’s future approach to trade deals with non-EU nations, the BGMA has insisted that there must be no changes to patent and exclusivity provisions that would block market entry for generic and biosimilar medicines.

Dept_International_Trade
The BGMA Responded To The Latest Statements From The UK’s Department For International Trade • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin